Samuel Kintz

Insider Reports History

Entity
Individual
Location
Enliven Therapeutics Inc, 6200 Lookout Road, Boulder, CO
Signature
/s/ Ben Hohl, by power of attorney
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Samuel Kintz:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Enliven Therapeutics, Inc. PRESIDENT AND CEO, Director Common Stock 1M $30.1M $30.00 Oct 18, 2024 Indirect
Enliven Therapeutics, Inc. PRESIDENT AND CEO, Director Stock Option (right to buy) 189K May 28, 2024 Direct

Insider Reports Filed by Samuel Kintz

Symbol Company Period Transactions Value $ Form Type Date Filed Role
ELVN Enliven Therapeutics, Inc. Oct 18, 2024 1 -$27.7K 4 Oct 22, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Oct 8, 2024 4 -$841K 4 Oct 10, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Oct 4, 2024 2 -$411K 4 Oct 8, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Oct 1, 2024 1 -$14.5K 4 Oct 3, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Aug 26, 2024 1 -$275K 4 Aug 28, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Jul 31, 2024 1 -$62.6K 4 Aug 2, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Jul 25, 2024 3 -$299K 4 Jul 29, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Jun 25, 2024 2 -$260K 4 Jun 27, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. May 28, 2024 5 -$265K 4 May 30, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Apr 25, 2024 3 -$189K 4 Apr 29, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Apr 11, 2024 3 -$1.14M 4 Apr 15, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Mar 25, 2024 4 -$197K 4 Mar 27, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Feb 26, 2024 4 -$189K 4 Feb 28, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Feb 13, 2024 1 $0 4 Feb 15, 2024 PRESIDENT AND CEO, Director
ELVN Enliven Therapeutics, Inc. Jan 25, 2024 4 -$175K 4 Jan 29, 2024 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Dec 26, 2023 3 -$162K 4 Dec 28, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Dec 21, 2023 6 -$97.7K 4 Dec 26, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Dec 20, 2023 3 -$92.5K 4 Dec 21, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Nov 3, 2023 3 -$96K 4 Nov 6, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Sep 25, 2023 3 -$152K 4 Sep 26, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Apr 4, 2023 1 $0 4 Apr 6, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 5 $0 4 Feb 27, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 President and CEO, Director
ELVN Enliven Therapeutics, Inc. Feb 23, 2023 0 $0 3 Feb 27, 2023 President and CEO, Director